BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29189326)

  • 1. Advances in the Genetics and Biology of Pancreatic Cancer.
    Aguirre AJ; Collisson EA
    Cancer J; 2017; 23(6):315-320. PubMed ID: 29189326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of oncogenic KRAS in pancreatic cancer (Review).
    Liu J; Ji S; Liang C; Qin Y; Jin K; Liang D; Xu W; Shi S; Zhang B; Liu L; Liu C; Xu J; Ni Q; Yu X
    Mol Med Rep; 2016 Jun; 13(6):4943-9. PubMed ID: 27121414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular aspects of carcinogenesis in pancreatic cancer.
    Koliopanos A; Avgerinos C; Paraskeva C; Touloumis Z; Kelgiorgi D; Dervenis C
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):345-56. PubMed ID: 18693168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Genetics of Pancreatic Neoplasms.
    Hosoda W; Wood LD
    Surg Pathol Clin; 2016 Dec; 9(4):685-703. PubMed ID: 27926367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.
    Hidalgo M; Von Hoff DD
    Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
    Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
    J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer biology and genetics.
    Bardeesy N; DePinho RA
    Nat Rev Cancer; 2002 Dec; 2(12):897-909. PubMed ID: 12459728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype Adjusts Fibrotic Phenotype to Drive Pancreatic Cancer.
    Cancer Discov; 2016 Jun; 6(6):572. PubMed ID: 27150537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of GLI Underlies a Role for BET Bromodomains in Pancreatic Cancer Growth and the Tumor Microenvironment.
    Huang Y; Nahar S; Nakagawa A; Fernandez-Barrena MG; Mertz JA; Bryant BM; Adams CE; Mino-Kenudson M; Von Alt KN; Chang K; Conery AR; Hatton C; Sims RJ; Fernandez-Zapico ME; Wang X; Lillemoe KD; Fernández-Del Castillo C; Warshaw AL; Thayer SP; Liss AS
    Clin Cancer Res; 2016 Aug; 22(16):4259-70. PubMed ID: 27169995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-κB and RalB signaling pathways.
    Vasseur R; Skrypek N; Duchêne B; Renaud F; Martínez-Maqueda D; Vincent A; Porchet N; Van Seuningen I; Jonckheere N
    Biochim Biophys Acta; 2015 Dec; 1849(12):1375-84. PubMed ID: 26477488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up.
    Perera RM; Bardeesy N
    Cancer Discov; 2015 Dec; 5(12):1247-61. PubMed ID: 26534901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twists and turns in
    Maru Y; Hippo Y
    Aging (Albany NY); 2021 Nov; 13(22):24477-24479. PubMed ID: 34843447
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinicopathological Implications of Wingless/int1 (WNT) Signaling Pathway in Pancreatic Ductal Adenocarcinoma.
    Nakamoto M; Hisaoka M
    J UOEH; 2016 Mar; 38(1):1-8. PubMed ID: 26972939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele.
    Wu J; Liu X; Nayak SG; Pitarresi JR; Cuitiño MC; Yu L; Hildreth BE; Thies KA; Schilling DJ; Fernandez SA; Leone G; Ostrowski MC
    PLoS One; 2017; 12(9):e0184984. PubMed ID: 28934293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.
    Mazur PK; Siveke JT
    Gut; 2012 Oct; 61(10):1488-500. PubMed ID: 21873467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel targets in pancreatic cancer research.
    Kozak G; Blanco FF; Brody JR
    Semin Oncol; 2015 Feb; 42(1):177-87. PubMed ID: 25726061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early requirement of Rac1 in a mouse model of pancreatic cancer.
    Heid I; Lubeseder-Martellato C; Sipos B; Mazur PK; Lesina M; Schmid RM; Siveke JT
    Gastroenterology; 2011 Aug; 141(2):719-30, 730.e1-7. PubMed ID: 21684285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis.
    Qian J; Niu J; Li M; Chiao PJ; Tsao MS
    Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine.
    Knudsen ES; O'Reilly EM; Brody JR; Witkiewicz AK
    Gastroenterology; 2016 Jan; 150(1):48-63. PubMed ID: 26385075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.